Study links COPD with increased bacterial invasion

Vanderbilt University Medical Center news release Chronic obstructive pulmonary disease (COPD) is a common smoking-related lung illness and the third leading cause of death in the United States. Scientists have long believed that inhaling toxic gases and particles from tobacco smoke causes inflammation of the small airways in the lungs, leading to the development of…

Penn Team Pinpoints Developmental Gene that Regulates Repair and Regeneration in Adult Lungs

Penn Medicine news release New role for hedgehog gene offers better understanding of lung disease PHILADELPHIA – The whimsically named sonic hedgehog gene, best known for controlling embryonic development, also maintains the normal physiological state and repair process of an adult healthy lung, if damaged, according to new research from the Perelman School of Medicine…

VirScan Reveals Viral History in a Drop of Blood

Brigham and Women’s Hospital press release From a single drop of blood, researchers can now simultaneously test for more than 1,000 different strains of viruses that currently or have previously infected a person. Using a new method known as VirScan, researchers from Brigham and Women’s Hospital (BWH) and Harvard Medical School tested for evidence of…

COPD Foundation Enrolls First Patient in Patient-Powered Research Network, First Step in Advancing COPD Research

COPD Foundation news release Celebrating its 10th anniversary, THE COPD FOUNDATION (COPDF) announces today that it has enrolled the first patient in the COPD Patient- Powered Research Network (COPD PPRN), one of 29 health data networks connected to PCORnet, the NATIONAL PATIENT-CENTERED CLINICAL RESEARCH NETWORK. Funded by the PATIENT-CENTERED OUTCOMES RESEARCH INSTITUTE (PCORI), this new…

Respiratory Disease Breakthrough

University of Newcastle news release Sinister specks of a molecule known as ASC are escaping from cells then coursing through the body to exacerbate the biological inflammatory response in major airway diseases such as asthma and emphysema. That is the ground-breaking discovery, just published in the international journal Nature Immunology, resulting from a collaboration between University…

Fat Damages the Lungs of Heavy Drinkers

Alcohol causes fat build-up in the lungs of rats, impairing immune function and possibly explaining why alcoholics are more likely to develop lung disease Heavy drinking damages the body in many ways. In addition to liver failure, alcoholics are at a much greater risk of developing pneumonia and life threatening acute respiratory distress syndrome (ARDS),…

Groundbreaking lung cancer trial launched – UC Davis expert David Gandara a key architect of national effort

UC Davis Health System press release UC Davis Comprehensive Cancer Center patients will soon be part of an unprecedented clinical trial designed to improve access to promising therapies and speed development of effective treatments for an advanced form of lung cancer, the leading cancer killer of both men and women. The approach, known as Lung-MAP…

Temple University Hospital Investigating Whether Ibuprofen Can Reverse the Effects of Emphysema

Temple Health News Release Temple University Hospital is participating in a multi-site, nationwide phase II clinical trial that is testing whether ibuprofen can reverse the effects of emphysema. Temple is one of only three medical centers in the country, and the only one in the Philadelphia region, chosen to take part in the three-year, $4.4 million…

Honey is a new approach to fighting antibiotic resistance: How sweet it is!

This research was presented at a meeting of the American Chemical Society. Honey, that delectable condiment for breads and fruits, could be one sweet solution to the serious, ever-growing problem of bacterial resistance to antibiotics, researchers said here today. Medical professionals sometimes use honey successfully as a topical dressing, but it could play a larger…

Evidera Announces Release of FDA Draft Guidance on Use of the “EXACT” to Measure Symptoms of COPD Exacerbations

BETHESDA, Md., Jan. 14, 2014 /PRNewswire/ — Evidera, a leading provider of evidence-based solutions for the healthcare industry, announced that the Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration, has released its first draft qualification guidance document for a patient-reported outcome (PRO) measure in drug development: Qualification of Exacerbations of Chronic…

Staph stoppers – New vaccine from University of Iowa protects against lethal pneumonia caused by staph bacteria

University of Iowa news release University of Iowa researchers have developed a new vaccine that protects against lethal pneumonia caused by Staphylococcus aureus (staph) bacteria, including drug-resistant strains like MRSA. The research team was led by Patrick Schlievert, professor and chair of microbiology in the UI Carver College of Medicine. The findings are published this…